Pfenex Inc. License Agreements
13 Contracts & Agreements
- Amendment No. 2 to the Development and License Agreement, dated June 24, 2020, between the Registrant and Alvogen Malta Operations Ltd (Filed With SEC on August 6, 2020)
- Amendment No. 3 to the Development and License Agreement, dated May 26, 2020, between the Registrant and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on August 6, 2020)
- Amendment No. 2 to the Development and License Agreement dated March 9, 2020, between the Registrant and Alvogen (Filed With SEC on May 7, 2020)
- Amendment No.1 to the Alvogen ROW Development and License Agreement (Filed With SEC on March 11, 2020)
- Amendment No. 1 to the Development and License Agreement dated February 25, 2019 between Pfenex Inc. and Alvogen Malta Operations Ltd (Filed With SEC on May 9, 2019)
- E.U. Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-licensing) Ltd (Filed With SEC on May 9, 2019)
- MENA Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on May 9, 2019)
- Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on May 9, 2019)
- Development and License Agreement, dated June 11, 2018, between the Registrant and Alvogen Malta Operations Ltd (Filed With SEC on August 8, 2018)
- Development and License Agreement, dated April 18, 2018, between the Registrant and China NT Pharma Group Company Limited (Filed With SEC on August 8, 2018)
- Amended License and Option Agreement, dated December 19, 2017, by and between the Registrant and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on March 15, 2018)
- GRANT-BACK AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on June 5, 2014)
- JOINT DEVELOPMENT & LICENSE AGREEMENT (Filed With SEC on June 5, 2014)
